<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04526535</url>
  </required_header>
  <id_info>
    <org_study_id>IIBSP-ECO-2019-105</org_study_id>
    <nct_id>NCT04526535</nct_id>
  </id_info>
  <brief_title>Prognostic Value of Lung Ultrasound in ST Segment Elevation Acute Myocardial Infarction (LUS-AMI)</brief_title>
  <acronym>LUS-AMI</acronym>
  <official_title>Prognostic Value of Lung Ultrasound in ST Segment Elevation Acute Myocardial Infarction (LUS-AMI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut Hospital del Mar d'Investigacions Médiques</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to asses the prognostic value of lung ultrasound in patients&#xD;
      with ST-segment elevation acute myocardial infarction.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      LUS-AMI is an observational cohort prospective study that evaluates the prognostic value of&#xD;
      lung ultrasound, specifically the number of B-lines, performed within the first 24 hours&#xD;
      after and ST-segment elevation acute myocardial infarction, by an independent operator&#xD;
      blinded to clinical outcomes and off-line analysis by another independent operator also&#xD;
      blinded to clinical outcomes.&#xD;
&#xD;
      Follow-up is six months after STEMI and the primary outcome is a composite of any cause&#xD;
      mortality, hospitalization secondary to cardiovascular disease (acute coronary syndrome,&#xD;
      heart failure or stroke) or need for urgent coronary revascularization. Secondary outcomes&#xD;
      are each event composing primary outcome separately, new onset heart failure during&#xD;
      hospitalization, acute kidney injury during hospitalization, new onset clinically relevant&#xD;
      arrythmia (atrial fibrillation, atrial flutter, ventricular tachycardia, ventricular&#xD;
      fibrillation) or unexpected consultation secondary to heart failure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 15, 2020</start_date>
  <completion_date type="Anticipated">June 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Primary combined outcome: incidence of any cause mortality, hospitalization secondary to cardiovascular cause or urgent requirement of coronary revascularization.</measure>
    <time_frame>Up to 6 months</time_frame>
    <description>Combined outcome of: mortality from any cause, readmission due to cardiovascular cause (acute coronary syndrome, heart failure or stroke) or the need for urgent coronary revascularization at a 6-month follow-up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart failure during hospitalization</measure>
    <time_frame>Until discharge from the hospital (an average of 1 week) or up to one month after admission</time_frame>
    <description>Heart failure, defined as compatible clinical syndrome and elevated natriuretic peptides (&gt; 450 pg / dl in &lt;50 years,&gt; 900 pg / dl in 50-75 years or&gt; 1800 pg / dl in&gt; 75 years), chest X ray with signs of heart failure or diuretic requirement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute renal injury during hospitalization</measure>
    <time_frame>Until discharge from the hospital (an average of 1 week) or up to one month after admission</time_frame>
    <description>Acute Kidney Injury Network (AKIN) criteria I, II or III or hemodialysis requirement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart failure during follow-up</measure>
    <time_frame>Up to 6 months</time_frame>
    <description>Unexpected visit (ambulatory or emergency room) secondary to clinical syndrome compatible with heart failure, with diuretics requirement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality from any cause during follow-up</measure>
    <time_frame>Up to 6 months</time_frame>
    <description>All-cause mortality up to a 6 months follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalization due to cardiovascular cause during follow-up</measure>
    <time_frame>Up to 6 months</time_frame>
    <description>Hospitalization during follow-up secondary to acute coronary syndrome, heart failure or stroke.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urgent coronary revascularization during follow-up</measure>
    <time_frame>Up to 6 months</time_frame>
    <description>Need for unexpected or unpredictable coronary revascularization due to symptoms of angina or acute coronary syndrome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Development of arrhythmias during follow-up</measure>
    <time_frame>Up to 6 months</time_frame>
    <description>New-onset atrial fibrillation, atrial flutter, sustained ventricular tachycardia or ventricular fibrillation during hospitalization and during follow-up</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Acute Myocardial Infarction</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>No B-lines</arm_group_label>
    <description>Patients with no significant B lines in the lung ultrasound at first 24 hours after acute myocardial infarction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B lines</arm_group_label>
    <description>Patients with significant B lines in the lung ultrasound at first 24 hours after acute myocardial infarction (pending establishing an optimal cut-off point)</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Lung ultrasound</intervention_name>
    <description>Lung ultrasound performed with a portable device with an 8 zones protocol within the first 24 hours after and acute myocardial infarction</description>
    <arm_group_label>B lines</arm_group_label>
    <arm_group_label>No B-lines</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All adults admitted with STEMI during 1 year in two terciary centers who meet inclusion&#xD;
        criteria.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults (more than 18 years) admitted with ST segment elevation acute myocardial&#xD;
             infarction (STEMI).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Absence of coronary artery disease and myocardial injury (false positive)&#xD;
&#xD;
          -  Non interpretable lung ultrasound&#xD;
&#xD;
          -  Severe lung disease (fibrosis, chronic pulmonary obstructive disease with domiciliary&#xD;
             oxygen therapy, pleural disease)&#xD;
&#xD;
          -  Acute respiratory distress syndrome&#xD;
&#xD;
          -  Pneumonia at admission or during hospitalization&#xD;
&#xD;
          -  Follow-up inability&#xD;
&#xD;
          -  Hemodialysis therapy previous to admission&#xD;
&#xD;
          -  Life expectancy less than 6 months secondary to extracardiac pathology.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jose Carreras-Mora, MD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jose Carreras-Mora, MD.</last_name>
    <phone>932483000</phone>
    <phone_ext>+ 34</phone_ext>
    <email>jcarrerasmora@parcdesalutmar.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Carreras-Mora, MD.</last_name>
    </contact>
    <investigator>
      <last_name>Alessandro Sionis, MD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Vidal-Burdeus, MD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Clara Simon-Ramon, MD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jordi Sans-Rosello, MD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Montserrat Vila-Perales, MD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Albert Duran-Cambra, MD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Carreras-Mora, MD.</last_name>
    </contact>
    <investigator>
      <last_name>Nuria Ribas-Barquet, MD. PhD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Teresa Giralt-Bordell, MD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrea Izquierdo-Marquisa, MD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jose Carreras-Mora, MD.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <results_reference>
    <citation>Farré N, Fort A, Tizón-Marcos H, et al. Epidemiology of heart failure in myocardial infarction treated with primary angioplasty: Analysis of the Codi IAM registry. REC: CardioClinics 2019;54:41-49.</citation>
  </results_reference>
  <results_reference>
    <citation>Araujo GND, Marques F, Scolari F, et al. Comparison of Lung Ultrasound and Killip Classification in Patients with St-Segment Elevation Myocardial Infarction Submitted to Coronary Angiography. J Am Coll Cardiol 2019;73:182.</citation>
  </results_reference>
  <results_reference>
    <citation>Lichtenstein DA. BLUE-protocol and FALLS-protocol: two applications of lung ultrasound in the critically ill. Chest. 2015 Jun;147(6):1659-1670. doi: 10.1378/chest.14-1313. Review.</citation>
    <PMID>26033127</PMID>
  </results_reference>
  <results_reference>
    <citation>Pivetta E, Goffi A, Lupia E, Tizzani M, Porrino G, Ferreri E, Volpicelli G, Balzaretti P, Banderali A, Iacobucci A, Locatelli S, Casoli G, Stone MB, Maule MM, Baldi I, Merletti F, Cibinel GA, Baron P, Battista S, Buonafede G, Busso V, Conterno A, Del Rizzo P, Ferrera P, Pecetto PF, Moiraghi C, Morello F, Steri F, Ciccone G, Calasso C, Caserta MA, Civita M, Condo' C, D'Alessandro V, Del Colle S, Ferrero S, Griot G, Laurita E, Lazzero A, Lo Curto F, Michelazzo M, Nicosia V, Palmari N, Ricchiardi A, Rolfo A, Rostagno R, Bar F, Boero E, Frascisco M, Micossi I, Mussa A, Stefanone V, Agricola R, Cordero G, Corradi F, Runzo C, Soragna A, Sciullo D, Vercillo D, Allione A, Artana N, Corsini F, Dutto L, Lauria G, Morgillo T, Tartaglino B, Bergandi D, Cassetta I, Masera C, Garrone M, Ghiselli G, Ausiello L, Barutta L, Bernardi E, Bono A, Forno D, Lamorte A, Lison D, Lorenzati B, Maggio E, Masi I, Maggiorotto M, Novelli G, Panero F, Perotto M, Ravazzoli M, Saglio E, Soardo F, Tizzani A, Tizzani P, Tullio M, Ulla M, Romagnoli E; SIMEU Group for Lung Ultrasound in the Emergency Department in Piedmont. Lung Ultrasound-Implemented Diagnosis of Acute Decompensated Heart Failure in the ED: A SIMEU Multicenter Study. Chest. 2015 Jul;148(1):202-210. doi: 10.1378/chest.14-2608.</citation>
    <PMID>25654562</PMID>
  </results_reference>
  <results_reference>
    <citation>Lichtenstein D, Goldstein I, Mourgeon E, Cluzel P, Grenier P, Rouby JJ. Comparative diagnostic performances of auscultation, chest radiography, and lung ultrasonography in acute respiratory distress syndrome. Anesthesiology. 2004 Jan;100(1):9-15.</citation>
    <PMID>14695718</PMID>
  </results_reference>
  <results_reference>
    <citation>Coiro S, Rossignol P, Ambrosio G, Carluccio E, Alunni G, Murrone A, Tritto I, Zannad F, Girerd N. Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure. Eur J Heart Fail. 2015 Nov;17(11):1172-81. doi: 10.1002/ejhf.344. Epub 2015 Sep 29.</citation>
    <PMID>26417699</PMID>
  </results_reference>
  <results_reference>
    <citation>Platz E, Lewis EF, Uno H, Peck J, Pivetta E, Merz AA, Hempel D, Wilson C, Frasure SE, Jhund PS, Cheng S, Solomon SD. Detection and prognostic value of pulmonary congestion by lung ultrasound in ambulatory heart failure patients. Eur Heart J. 2016 Apr 14;37(15):1244-51. doi: 10.1093/eurheartj/ehv745. Epub 2016 Jan 26.</citation>
    <PMID>26819225</PMID>
  </results_reference>
  <results_reference>
    <citation>Rivas-Lasarte M, Álvarez-García J, Fernández-Martínez J, Maestro A, López-López L, Solé-González E, Pirla MJ, Mesado N, Mirabet S, Fluvià P, Brossa V, Sionis A, Roig E, Cinca J. Lung ultrasound-guided treatment in ambulatory patients with heart failure: a randomized controlled clinical trial (LUS-HF study). Eur J Heart Fail. 2019 Dec;21(12):1605-1613. doi: 10.1002/ejhf.1604. Epub 2019 Oct 31.</citation>
    <PMID>31667987</PMID>
  </results_reference>
  <results_reference>
    <citation>Januzzi JL, van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordonez-Llanos J, Santalo-Bel M, Pinto YM, Richards M. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J. 2006 Feb;27(3):330-7. Epub 2005 Nov 17.</citation>
    <PMID>16293638</PMID>
  </results_reference>
  <results_reference>
    <citation>Platz E, Jhund PS, Girerd N, Pivetta E, McMurray JJV, Peacock WF, Masip J, Martin-Sanchez FJ, Miró Ò, Price S, Cullen L, Maisel AS, Vrints C, Cowie MR, DiSomma S, Bueno H, Mebazaa A, Gualandro DM, Tavares M, Metra M, Coats AJS, Ruschitzka F, Seferovic PM, Mueller C; Study Group on Acute Heart Failure of the Acute Cardiovascular Care Association and the Heart Failure Association of the European Society of Cardiology. Expert consensus document: Reporting checklist for quantification of pulmonary congestion by lung ultrasound in heart failure. Eur J Heart Fail. 2019 Jul;21(7):844-851. doi: 10.1002/ejhf.1499. Epub 2019 Jun 19.</citation>
    <PMID>31218825</PMID>
  </results_reference>
  <results_reference>
    <citation>Ye XJ, Li N, Li JH, Wu WJ, Li AL, Li XL. B-lines by lung ultrasound predict heart failure in hospitalized patients with acute anterior wall STEMI. Echocardiography. 2019 Jul;36(7):1253-1262. doi: 10.1111/echo.14420. Epub 2019 Jul 9.</citation>
    <PMID>31287587</PMID>
  </results_reference>
  <results_reference>
    <citation>Araujo GN, Silveira AD, Scolari FL, Custodio JL, Marques FP, Beltrame R, Menegazzo W, Machado GP, Fuchs FC, Goncalves SC, Wainstein RV, Leiria TL, Wainstein MV. Admission Bedside Lung Ultrasound Reclassifies Mortality Prediction in Patients With ST-Segment-Elevation Myocardial Infarction. Circ Cardiovasc Imaging. 2020 Jun;13(6):e010269. doi: 10.1161/CIRCIMAGING.119.010269. Epub 2020 Jun 15.</citation>
    <PMID>32536197</PMID>
  </results_reference>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>July 24, 2020</study_first_submitted>
  <study_first_submitted_qc>August 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 26, 2020</study_first_posted>
  <last_update_submitted>August 24, 2020</last_update_submitted>
  <last_update_submitted_qc>August 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lung Ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

